![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Tsongalis Gregory J. Ricci Jr. Andrew
Publisher: Informa Healthcare
ISSN: 1040-8363
Source: Critical Reviews in Clinical Laboratory Sciences, Vol.38, Iss.2, 1998-03, pp. : 167-182
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
HER2/neu vaccines in breast cancer
By Khoo Steven Ponniah Sathibalan Peoples George E
Women's Health, Vol. 2, Iss. 2, 2006-03 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Targeting Her-2/neu in Breast Cancer: As Easy as This!
Oncology, Vol. 74, Iss. 3-4, 2008-08 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
HER2 as a Prognostic Factor in Breast Cancer
Oncology, Vol. 61, Iss. 2, 2001-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Prognostic Values of p53 and HER-2/neu Coexpression in Invasive Bladder Cancer in Taiwan
Urologia Internationalis, Vol. 71, Iss. 3, 2003-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Oncology, Vol. 68, Iss. 2-3, 2005-07 ,pp. :